Inner-City Anti-IgE Therapy for Asthma

NCT00377572 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

419

Enrollment

NIH

Sponsor class

Conditions

Asthma

Interventions

BIOLOGICAL: omalizumab
BIOLOGICAL: omalizumab placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]